GENBGenerate Biomedicines, Inc.
$12.41
$12.41
$11.2152 weeks$20.40
What is the market doing?
Mixed
2 neutral, 1 without dataNo clear lean: insiders net selling (often routine) and moderately shorted.
Insider conviction−$16K (90 days to Oct 22, 2026)SEC EDGAR · Oct 22, 2026
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Short interest5.8% of sharesFINRA · Sep 30, 2026
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 3.3% since the previous count, up from 4.6% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How GENB is trading
- Below its 52-week high
- 39%
Below its 52-week high
Details›
- Last close2026-10-23
- $12.41
- 1 monthS&P 500 −0.94%
- −22%
- 52-week high
- $20.40
- 52-week low
- $11.21
- Annualised volatility
- 86%
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry